The right tools at the right time: Liquid Biopsy enters the clinic

The field of clinical oncology continues to see drastic advancements with non-invasive techniques, such as liquid biopsy being adopted for diagnosing and monitoring cancers in place of more invasive methods. Liquid biopsies consist of isolating tumor-derived entities like circulating tumor cells, circulating tumor DNA, tumor extracellular vesicles, etc., present in the body fluids of patients with cancer. Liquid biopsies have the potential to change the diagnostic and prognostic landscape for cancer genotyping and impact patient management. However, several limitations still hamper the implementation of liquid biopsy in clinical practice. Register to learn how liquid biopsies may help with treatment selection and monitoring of cancer treatment outcomes and the current challenges limiting clinical practice adoption.